| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |